Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 295

1.

Significance of inducibility of atrial fibrillation after pulmonary vein isolation in patients with healthy left atrium substrate.

Kosiuk J, Gründig S, Dinov B, Müssigbrodt A, Richter S, Sommer P, Hindricks G, Bollmann A.

J Cardiovasc Electrophysiol. 2019 Oct 18. doi: 10.1111/jce.14234. [Epub ahead of print]

PMID:
31626352
2.

Combined single-session cardiovascular magnetic resonance: stress perfusion and three-dimensional pulmonary vein angiography for stratification of atrial fibrillation patients with chest pain syndromes prior to catheter ablation.

Oebel S, Paetsch I, Stegmann C, Kircher S, Sommer P, Arya A, Lindemann F, Bollmann A, Hindricks G, Jahnke C.

Europace. 2019 Sep 12. pii: euz248. doi: 10.1093/europace/euz248. [Epub ahead of print]

PMID:
31513245
3.

Very late arrhythmia recurrences in patients with sinus rhythm within the first year after catheter ablation: The Leipzig Heart Center AF Ablation Registry.

Kornej J, Schumacher K, Sommer P, Potpara T, Arya A, Dagres N, Bollmann A, Husser-Bollmann D, Lip GYH, Hindricks G.

Europace. 2019 Aug 22. pii: euz233. doi: 10.1093/europace/euz233. [Epub ahead of print]

PMID:
31504447
4.

Pain During "Noncomplex" Electrophysiological Studies and Cardiac Rhythm Device Surgery.

Fikenzer S, Fikenzer K, Bauer Y, Kuehl M, Hindricks G, Bollmann A, Bode K.

J Cardiovasc Nurs. 2019 Nov/Dec;34(6):517-527. doi: 10.1097/JCN.0000000000000601.

PMID:
31441801
5.

Correction: Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Müssigbrodt A, Czimbalmos C, Stauber A, Bertagnolli L, Bode K, Dagres N, Döring M, Richter S, Sommer P, Husser D, Bollmann A, Hindricks G, Arya A.

Int J Sports Med. 2019 Sep;40(10):e1. doi: 10.1055/a-0983-9023. Epub 2019 Aug 1. No abstract available.

PMID:
31370066
6.

Effect of remote ischemic preconditioning on electrophysiological parameters in nonvalvular paroxysmal atrial fibrillation: The RIPPAF Randomized Clinical Trial.

Kosiuk J, Langenhan K, Stegmann C, Uhe T, Dagres N, Dinov B, Kircher S, Richter S, Sommer P, Bertagnolli L, Bollmann A, Hindricks G.

Heart Rhythm. 2019 Jul 26. pii: S1547-5271(19)30667-8. doi: 10.1016/j.hrthm.2019.07.026. [Epub ahead of print]

PMID:
31356986
7.

Effect of Exercise on Outcome after Ventricular Tachycardia Ablation in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.

Müssigbrodt A, Czimbalmos C, Stauber A, Bertagnolli L, Bode K, Dagres N, Döring M, Richter S, Sommer P, Husser D, Bollmann A, Hindricks G, Arya A.

Int J Sports Med. 2019 Sep;40(10):657-662. doi: 10.1055/a-0962-1325. Epub 2019 Jul 23. Erratum in: Int J Sports Med. 2019 Sep;40(10):e1.

PMID:
31342478
8.

Initial rivaroxaban dosing in patients with atrial fibrillation.

Ablefoni K, Buchholz A, Ueberham L, Hilbert S, Dagres N, Husser D, Hindricks G, Bollmann A.

Clin Cardiol. 2019 Oct;42(10):873-880. doi: 10.1002/clc.23235. Epub 2019 Jul 17.

9.

Atrial Fibrillation and Cognitive Impairment: New Insights and Future Directions.

Sepehri Shamloo A, Dagres N, Müssigbrodt A, Stauber A, Kircher S, Richter S, Dinov B, Bertagnolli L, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A.

Heart Lung Circ. 2019 Jun 21. pii: S1443-9506(19)31321-6. doi: 10.1016/j.hlc.2019.05.185. [Epub ahead of print] Review.

PMID:
31262618
10.

Myeloperoxidase in atrial fibrillation: association with progression, origin and influence of renin-angiotensin system antagonists.

Holzwirth E, Kornej J, Erbs S, Obradovic D, Bollmann A, Hindricks G, Thiele H, Büttner P.

Clin Res Cardiol. 2019 Jun 24. doi: 10.1007/s00392-019-01512-z. [Epub ahead of print]

PMID:
31236695
11.

Outcome in patients undergoing upgrade to cardiac resynchronization therapy: predictors of outcome after upgrade to CRT.

Kosiuk J, Krause M, Doering M, Weber A, Breithardt OA, Dinov B, Darma A, Lucas J, Muessigbrodt A, Bode K, Kuehl M, Dagres N, Hindricks G, Bollmann A, Richter S.

Heart Vessels. 2019 Jun 21. doi: 10.1007/s00380-019-01449-3. [Epub ahead of print]

PMID:
31227877
12.

Epicardial adipose tissue thickness as an independent predictor of ventricular tachycardia recurrence following ablation.

Sepehri Shamloo A, Schoene K, Stauber A, Darma A, Dagres N, Dinov B, Bertagnolli L, Hilbert S, Müssigbrodt A, Husser D, Bollmann A, Hindricks G, Arya A.

Heart Rhythm. 2019 Oct;16(10):1492-1498. doi: 10.1016/j.hrthm.2019.06.009. Epub 2019 Jun 14.

PMID:
31202898
13.

Cardiovascular magnetic resonance imaging in patients with cardiac implantable electronic devices: best practice and real-world experience.

Seewöster T, Löbe S, Hilbert S, Bollmann A, Sommer P, Lindemann F, Bacevičius J, Schöne K, Richter S, Döring M, Paetsch I, Hindricks G, Jahnke C.

Europace. 2019 May 25. pii: euz112. doi: 10.1093/europace/euz112. [Epub ahead of print]

PMID:
31131393
14.

Value of Cardiogoniometry in Diagnosis of Coronary Artery Disease in Patients with Suspected Stable Ischemic Heart Disease: A Systematic Review and Meta-Analysis.

Shamloo AS, Dinov B, Bertagnolli L, Sommer P, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A.

Int Heart J. 2019 May 30;60(3):527-538. doi: 10.1536/ihj.18-391. Epub 2019 May 17.

15.

Agreement between gadolinium-enhanced cardiac magnetic resonance and electro-anatomical maps in patients with non-ischaemic dilated cardiomyopathy and ventricular arrhythmias.

Torri F, Czimbalmos C, Bertagnolli L, Oebel S, Bollmann A, Paetsch I, Jahnke C, Arya A, Merkely B, Hindricks G, Dinov B.

Europace. 2019 Sep 1;21(9):1392-1399. doi: 10.1093/europace/euz127.

PMID:
31102521
16.

Atrial fibrillation is associated with alterations in HDL function, metabolism, and particle number.

Trieb M, Kornej J, Knuplez E, Hindricks G, Thiele H, Sommer P, Scharnagl H, Dagres N, Dinov B, Bollmann A, Husser D, Marsche G, Buettner P.

Basic Res Cardiol. 2019 May 8;114(4):27. doi: 10.1007/s00395-019-0735-0.

PMID:
31069509
17.

Time-dependent prediction of arrhythmia recurrences during long-term follow-up in patients undergoing catheter ablation of atrial fibrillation: The Leipzig Heart Center AF Ablation Registry.

Kornej J, Schumacher K, Zeynalova S, Sommer P, Arya A, Weiß M, Piorkowski C, Husser D, Bollmann A, Lip GYH, Hindricks G.

Sci Rep. 2019 May 8;9(1):7112. doi: 10.1038/s41598-019-43644-2.

18.

A Physiological and Genomic Comparison of Nitrosomonas Cluster 6a and 7 Ammonia-Oxidizing Bacteria.

Sedlacek CJ, McGowan B, Suwa Y, Sayavedra-Soto L, Laanbroek HJ, Stein LY, Norton JM, Klotz MG, Bollmann A.

Microb Ecol. 2019 Apr 11. doi: 10.1007/s00248-019-01378-8. [Epub ahead of print]

PMID:
30976841
19.

Complete Genome Sequence for Asinibacterium sp. Strain OR53 and Draft Genome Sequence for Asinibacterium sp. Strain OR43, Two Bacteria Tolerant to Uranium.

Brzoska RM, Huntemann M, Clum A, Chen A, Kyrpides N, Palaniappan K, Ivanova N, Mikhailova N, Ovchinnikova G, Varghese N, Mukherjee S, Reddy TBK, Daum C, Shapiro N, Woyke T, Bollmann A.

Microbiol Resour Announc. 2019 Apr 4;8(14). pii: e01701-18. doi: 10.1128/MRA.01701-18.

20.

Affinity informs environmental cooperation between ammonia-oxidizing archaea (AOA) and anaerobic ammonia-oxidizing (Anammox) bacteria.

Straka LL, Meinhardt KA, Bollmann A, Stahl DA, Winkler MH.

ISME J. 2019 Aug;13(8):1997-2004. doi: 10.1038/s41396-019-0408-x. Epub 2019 Apr 1.

PMID:
30936420
21.

EGF (Epidermal Growth Factor) Receptor Ligands in Atrial Fibrillation.

Büttner P, Werner S, Sommer P, Burkhardt R, Zeynalova S, Baber R, Bollmann A, Husser-Bollmann D, Thiery J, Hindricks G, Thiele H, Kornej J.

Circ Arrhythm Electrophysiol. 2019 Apr;12(4):e007212. doi: 10.1161/CIRCEP.119.007212. No abstract available.

PMID:
30894015
22.

Acute safety, effectiveness, and real-world clinical usage of ultra-high density mapping for ablation of cardiac arrhythmias: results of the TRUE HD study.

Hindricks G, Weiner S, McElderry T, Jaïs P, Maddox W, Garcia-Bolao JI, Yong Ji S, Sacher F, Willems S, Mounsey J, Maury P, Bollmann A, Duffy E, Raciti G, Tung R, Wong T.

Europace. 2019 Apr 1;21(4):655-661. doi: 10.1093/europace/euy191.

23.

Is epicardial fat tissue associated with atrial fibrillation recurrence after ablation? A systematic review and meta-analysis.

Sepehri Shamloo A, Dagres N, Dinov B, Sommer P, Husser-Bollmann D, Bollmann A, Hindricks G, Arya A.

Int J Cardiol Heart Vasc. 2019 Jan 26;22:132-138. doi: 10.1016/j.ijcha.2019.01.003. eCollection 2019 Mar.

24.

What you extract is what you see: Optimising the preparation of water and wastewater samples for in vitro bioassays.

Abbas A, Schneider I, Bollmann A, Funke J, Oehlmann J, Prasse C, Schulte-Oehlmann U, Seitz W, Ternes T, Weber M, Wesely H, Wagner M.

Water Res. 2019 Apr 1;152:47-60. doi: 10.1016/j.watres.2018.12.049. Epub 2019 Jan 2.

PMID:
30660097
25.

Left Atrial Asynchrony Measured by Pulsed-Wave Tissue Doppler Is Associated With Abnormal Atrial Voltage and Recurrences of Atrial Fibrillation After Catheter Ablation.

Löbe S, Knopp H, Le TV, Nedios S, Seewöster T, Bode K, Sommer P, Bollmann A, Hindricks G, Dinov B.

JACC Clin Electrophysiol. 2018 Dec;4(12):1640-1641. doi: 10.1016/j.jacep.2018.08.017. No abstract available.

PMID:
30573131
26.

Morphological determinators of platelet activation status in patients with atrial fibrillation.

Kosiuk J, Uhe T, Stegmann C, Ueberham L, Bertagnolli L, Dagres N, Dinov B, Müssigbrodt A, Richter S, Paetsch I, Jahnke C, Hilbert S, Sommer P, Hindricks G, Bollmann A.

Int J Cardiol. 2019 Mar 15;279:90-95. doi: 10.1016/j.ijcard.2018.11.096. Epub 2018 Nov 17.

PMID:
30503184
27.

Circulating proteomic patterns in AF related left atrial remodeling indicate involvement of coagulation and complement cascade.

Kornej J, Büttner P, Hammer E, Engelmann B, Dinov B, Sommer P, Husser D, Hindricks G, Völker U, Bollmann A.

PLoS One. 2018 Nov 29;13(11):e0198461. doi: 10.1371/journal.pone.0198461. eCollection 2018.

28.

[Medically Unexplained Symptoms].

Fábián B, Bollmann A K, Bugán A.

Psychiatr Hung. 2018;33(3):236-242. Hungarian.

PMID:
30426930
29.

Association between PR interval prolongation and electro-anatomical substrate in patients with atrial fibrillation.

Schumacher K, Büttner P, Dagres N, Sommer P, Dinov B, Hindricks G, Bollmann A, Kornej J.

PLoS One. 2018 Nov 5;13(11):e0206933. doi: 10.1371/journal.pone.0206933. eCollection 2018.

30.

Association Between Cardiovascular Magnetic Resonance-Derived Left Atrial Dimensions, Electroanatomical Substrate and NT-proANP Levels in Atrial Fibrillation.

Seewöster T, Büttner P, Nedios S, Sommer P, Dagres N, Schumacher K, Bollmann A, Hilbert S, Jahnke C, Paetsch I, Hindricks G, Kornej J.

J Am Heart Assoc. 2018 Oct 2;7(19):e009427. doi: 10.1161/JAHA.118.009427.

31.

Anything that can be measured can be improved: the case of performance measures in heart failure and beyond.

Bollmann A, Hindricks G.

Eur Heart J Qual Care Clin Outcomes. 2019 Jan 1;5(1):4-5. doi: 10.1093/ehjqcco/qcy051. No abstract available.

PMID:
30346505
32.

[Investigation of sleep and fatigue in patients with cancer].

Bollmann AK, Fábián B, Molnár J.

Orv Hetil. 2018 Oct;159(42):1720-1726. doi: 10.1556/650.2018.31154. Hungarian.

PMID:
30334487
33.

Rate of acquired pulmonary vein stenosis after ablation of atrial fibrillation referred to electroanatomical mapping systems: Does it matter?

Schoene K, Arya A, Jahnke C, Paetsch I, Dagres N, Bollmann A, Hindricks G, Sommer P.

Cardiol J. 2018 Sep 24. doi: 10.5603/CJ.a2018.0114. [Epub ahead of print]

34.

Catheter ablation of atrial fibrillation with nonfluoroscopic catheter visualization-a prospective randomized comparison.

Rolf S, Schoene K, Kircher S, Dinov B, Bertagnolli L, Bollmann A, Richter S, Arya A, Hindricks G, Sommer P.

J Interv Card Electrophysiol. 2019 Jan;54(1):35-42. doi: 10.1007/s10840-018-0446-8. Epub 2018 Sep 18.

PMID:
30229406
35.

In-hospital mortality of patients with atrial arrhythmias: insights from the German-wide Helios hospital network of 161 502 patients and 34 025 arrhythmia-related procedures.

König S, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Seyfarth M, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Andrié R, Wetzel U, Neuser H, Wunderlich C, Kuhlen R, Tijssen JGP, Hindricks G, Bollmann A.

Eur Heart J. 2018 Nov 21;39(44):3947-3957. doi: 10.1093/eurheartj/ehy528.

PMID:
30165430
36.

Prediction of electro-anatomical substrate and arrhythmia recurrences using APPLE, DR-FLASH and MB-LATER scores in patients with atrial fibrillation undergoing catheter ablation.

Kornej J, Schumacher K, Dinov B, Kosich F, Sommer P, Arya A, Husser D, Bollmann A, Lip GYH, Hindricks G.

Sci Rep. 2018 Aug 23;8(1):12686. doi: 10.1038/s41598-018-31133-x.

37.

Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation for Atrial Fibrillation: Single-Center Experience in Catheter Interventional Treatment.

Schoene K, Arya A, Jahnke C, Paetsch I, Nedios S, Hilbert S, Bollmann A, Hindricks G, Sommer P.

JACC Cardiovasc Interv. 2018 Aug 27;11(16):1626-1632. doi: 10.1016/j.jcin.2018.05.016.

38.

Characteristics of the ablation lesions in cardiac magnetic resonance imaging after radiofrequency ablation of ventricular arrhythmias in relation to the procedural success.

Dinov B, Oebel S, Hilbert S, Loebe S, Arya A, Bollmann A, Sommer P, Jahnke C, Paetsch I, Hindricks G.

Am Heart J. 2018 Oct;204:68-75. doi: 10.1016/j.ahj.2018.06.014. Epub 2018 Aug 2.

PMID:
30077835
39.

[Three-dimensional mapping : Special aspects and new features of CARTO®].

Bertagnolli L, Torri F, Richter S, Dinov B, Müssigbrodt A, Arya A, Sommer P, Bollmann A, Hindricks G, Hilbert S.

Herzschrittmacherther Elektrophysiol. 2018 Sep;29(3):259-263. doi: 10.1007/s00399-018-0583-x. Epub 2018 Aug 3. Review. German.

PMID:
30076446
40.

Same-day discharge following atrial fibrillation catheter ablation: the perfect blend?

Ueberham L, Bollmann A.

Europace. 2019 Mar 1;21(3):363-365. doi: 10.1093/europace/euy169. No abstract available.

PMID:
30060187
41.

Label-free Imaging of Myocardial Remodeling in Atrial Fibrillation Using Nonlinear Optical Microscopy: A Feasibility Study.

Buttner P, Galli R, Husser D, Bollmann A.

J Atr Fibrillation. 2018 Feb 28;10(5):1644. doi: 10.4022/jafib.1644. eCollection 2018 Feb.

42.

Cardiac tamponade in catheter ablation of atrial fibrillation: German-wide analysis of 21 141 procedures in the Helios atrial fibrillation ablation registry (SAFER).

Bollmann A, Ueberham L, Schuler E, Wiedemann M, Reithmann C, Sause A, Tebbenjohanns J, Schade A, Shin DI, Staudt A, Zacharzowsky U, Ulbrich M, Wetzel U, Neuser H, Bode K, Kuhlen R, Hindricks G.

Europace. 2018 Dec 1;20(12):1944-1951. doi: 10.1093/europace/euy131.

PMID:
29982554
43.

Inguinal vascular complications after ablation of atrial fibrillation: an economic impact assessment.

Bode K, Ueberham L, Gawlik S, Hindricks G, Bollmann A.

Europace. 2019 Jan 1;21(1):91-98. doi: 10.1093/europace/euy132.

PMID:
29901719
44.

Prediction of electro-anatomical substrate using APPLE score and biomarkers.

Kornej J, Büttner P, Sommer P, Dagres N, Dinov B, Schumacher K, Bollmann A, Hindricks G.

Europace. 2019 Jan 1;21(1):54-59. doi: 10.1093/europace/euy120.

PMID:
29893827
45.

SAFER.

Ueberham L, Schuler E, Hindricks G, Kuhlen R, Bollmann A.

Eur Heart J. 2018 Jun 7;39(22):2023-2024. doi: 10.1093/eurheartj/ehy255. No abstract available.

PMID:
29878168
46.

Identification of Central Regulators of Calcium Signaling and ECM-Receptor Interaction Genetically Associated With the Progression and Recurrence of Atrial Fibrillation.

Büttner P, Ueberham L, Shoemaker MB, Roden DM, Dinov B, Hindricks G, Bollmann A, Husser D.

Front Genet. 2018 May 16;9:162. doi: 10.3389/fgene.2018.00162. eCollection 2018.

47.

Prevalence of clinically apparent hypertrophic cardiomyopathy in Germany-An analysis of over 5 million patients.

Husser D, Ueberham L, Jacob J, Heuer D, Riedel-Heller S, Walker J, Hindricks G, Bollmann A.

PLoS One. 2018 May 3;13(5):e0196612. doi: 10.1371/journal.pone.0196612. eCollection 2018.

48.

Novel Measure of Local Impedance Predicts Catheter-Tissue Contact and Lesion Formation.

Sulkin MS, Laughner JI, Hilbert S, Kapa S, Kosiuk J, Younan P, Romero I, Shuros A, Hamann JJ, Hindricks G, Bollmann A.

Circ Arrhythm Electrophysiol. 2018 Apr;11(4):e005831. doi: 10.1161/CIRCEP.117.005831.

PMID:
29618475
49.

Role of NT-proANP and NT-proBNP in patients with atrial fibrillation: Association with atrial fibrillation progression phenotypes.

Büttner P, Schumacher K, Dinov B, Zeynalova S, Sommer P, Bollmann A, Husser D, Hindricks G, Kornej J.

Heart Rhythm. 2018 Aug;15(8):1132-1137. doi: 10.1016/j.hrthm.2018.03.021. Epub 2018 Mar 29.

PMID:
29604419
50.

Initial apixaban dosing in patients with atrial fibrillation.

Buchholz A, Ueberham L, Gorczynska K, Dinov B, Hilbert S, Dagres N, Husser D, Hindricks G, Bollmann A.

Clin Cardiol. 2018 May;41(5):671-676. doi: 10.1002/clc.22949. Epub 2018 May 11.

Supplemental Content

Loading ...
Support Center